News - Galderma


Current filters:


Popular Filters

Valeant Pharma to sell filler and toxin assets to Nestle for $1.4 billion

Valeant Pharma to sell filler and toxin assets to Nestle for $1.4 billion


Acquisitive Canadian drugmaker Valeant Pharmaceuticals International has entered into an agreement to…

DermatologicalsGaldermaMergers & AcquisitionsNestlePharmaceuticalValeant Pharmaceuticals

Nestle takes full control of Galderma Pharma


The boards of Switzerland-based Nestle, the world’s largest food company, and French cosmetics firm…

DermatologicalsGaldermaMergers & AcquisitionsNestlePharmaceutical

Galderma drug is first FDA-approved facial erythema of rosacea treatment


Switzerland-headquartered Galderma Laboratories says that the US Food and Drug Administration has approved…

brimonidineDermatologicalsGaldermaMirvasoNorth AmericaPharmaceuticalRegulation

News briefs on Ipsen/Galderma and YM BioSciences nimotuzumab assets


French drugmaker Ipsen (Euronext: IPN) and Switzerland-headquartered Galderma have expanded their collaboration…

Asia-PacificBiotechnologyCIMABDysportGaldermaInnoKeys PTEIpsenLicensingnimotuzumabOncologyPharmaceuticalSouth AmericaYM Biosciences

Kyorin Pharma transfers Pekiron rights to Galderma


Japan's Kyorin Holdings (TYO: 4569), through its Kyorin Pharmaceuticals subsidiary, aiming to concentrate…

Asia-PacificDermatologicalsGaldermaKyorin PharmaceuticalsLicensingPekironPharmaceutical

Nuvo Research gets $6.0 million milestone on Pliaglis EU approvals


Canada-based specialty pharma firm Nuvo Research (TSX: NRI) announced that global commercial partner…

DermatologicalsEuropeFinancialGaldermaLicensingNuvo ResearchPharmaceuticalPliaglis

Back to top